Economic evaluation of integrated new technologies for health and social care: Suggestions for policy makers, users and evaluators.
暂无分享,去创建一个
[1] Lisa Wilfert,et al. Drivers of change , 2018, Australasian Physical & Engineering Sciences in Medicine.
[2] Roberto Veneziani,et al. Equality of When , 2017 .
[3] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[4] C. Salisbury,et al. Cost-effectiveness of telehealth for patients with depression: evidence from the Healthlines randomised controlled trial , 2016, BJPsych Open.
[5] J. Coast,et al. A Framework for Including Family Health Spillovers in Economic Evaluation , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.
[6] J. Brazier,et al. Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY , 2015, Applied Health Economics and Health Policy.
[7] J. Coast,et al. Assessing sufficient capability: A new approach to economic evaluation. , 2015, Social science & medicine.
[8] Karl Claxton,et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. , 2015, Health technology assessment.
[9] Peter McMeekin,et al. Can Aging in Place Be Cost Effective? A Systematic Review , 2014, PloS one.
[10] M. Chalkley,et al. Integrating funds for health and social care: an evidence review , 2014, Journal of health services research & policy.
[11] J. Wildman,et al. Health care and social care: complements, substitutes and attributes , 2014 .
[12] Cam Donaldson,et al. Q-ing for health--a new approach to eliciting the public's views on health care resource allocation. , 2014, Health economics.
[13] Jon Sussex,et al. Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold , 2013 .
[14] Martin Knapp,et al. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial , 2013, BMJ.
[15] Jennifer Dixon,et al. Effect of telecare on use of health and social care services: findings from the Whole Systems Demonstrator cluster randomised trial , 2013, Age and ageing.
[16] M. Ryan,et al. Deriving distributional weights for QALYs through discrete choice experiments. , 2011, Journal of health economics.
[17] I. Bateman,et al. The social value of a QALY: raising the bar or barring the raise? , 2011, BMC health services research.
[18] Afschin Gandjour,et al. Theoretical Foundation of Patient v. Population Preferences in Calculating QALYs , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.
[19] I. Bateman,et al. Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project. , 2010, Health technology assessment.
[20] J. Coast,et al. Welfarism, extra-welfarism and capability: the spread of ideas in health economics. , 2008, Social science & medicine.
[21] T. Peters,et al. Valuing the ICECAP capability index for older people. , 2008, Social science & medicine.
[22] J. Coast,et al. Should the capability approach be applied in health economics? , 2008, Health economics.
[23] J. Bond,et al. Developing attributes for a generic quality of life measure for older people: preferences or capabilities? , 2006, Social science & medicine.
[24] R. Cookson. QALYs and the capability approach. , 2005, Health economics.
[25] C. Donaldson,et al. Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism? , 2003, Social science & medicine.
[26] P. Dolan. Whose Preferences Count? , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[27] C. Donaldson. Valuing the benefits of publicly-provided health care: does 'ability to pay' preclude the use of 'willingness to pay'? , 1999, Social science & medicine.
[28] Seyed Hassan Ghodsypour,et al. A decision support system for supplier selection using an integrated analytic hierarchy process and linear programming , 1998 .
[29] A A Stinnett,et al. Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[30] John Mullahy,et al. Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis , 1998 .
[31] A. Culyer. THE NORMATIVE ECONOMICS OF HEALTH CARE FINANCE AND PROVISION , 1989 .
[32] M. Drummond,et al. Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .
[33] K. Lancaster. A New Approach to Consumer Theory , 1966, Journal of Political Economy.
[34] Wilson N Gathaiya. A decision support system for supplier selection , 2018 .
[35] Franziska Wulf,et al. Methods For The Economic Evaluation Of Health Care Programmes , 2016 .
[36] J. Hurley,et al. Welfarism and Extra-Welfarism , 2014 .
[37] Anthony J. Culyer,et al. The NICE Cost-Effectiveness Threshold , 2012, PharmacoEconomics.
[38] J. Brazier,et al. Outcomes of social care for adults: developing a preference-weighted measure. , 2012, Health technology assessment.
[39] F. Colombo. Help wanted? : providing and paying for long-term care , 2011 .
[40] S. Walker,et al. Appropriate perspectives for health care decisions. , 2010 .
[41] A. Culyer,et al. The NICE cost-effectiveness threshold: what it is and what that means. , 2008, PharmacoEconomics.
[42] T. Peters,et al. Best--worst scaling: What it can do for health care research and how to do it. , 2007, Journal of health economics.
[43] A. Brennan,et al. Should patients have a greater role in valuing health states? , 2005, Applied health economics and health policy.